Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia.
Level 4 - case-series / case-control
Case-control observational study comparing heterozygous carriers, affected patients, and healthy controls
PubMed 31805392 · doi:10.1016/j.jsbmb.2019.105554
What was done
Clinical, biochemical, and genetic characteristics were evaluated in a cohort of 57 Sicilian females with CYP21A2 mutations (24 with non-classical congenital adrenal hyperplasia [NC-CAH] bearing biallelic variants and 33 heterozygous CAH carriers bearing monoallelic variants) alongside 44 age-matched healthy female controls.
What was found
CYP21A2 heterozygous carriers presented with clinical features such as hirsutism, oligomenorrhoea, overweight, and a polycystic ovary (PCO)-like phenotype, especially manifesting in adolescence. Hormonal levels of 17-hydroxyprogesterone (17OHP) and cortisol in carriers were significantly different from NC-CAH patients. Oligomenorrhea and the 17OHP/cortisol ratio were identified as independent markers associated with carrier status. The abstract reports no exact numerical hormone levels, odds ratios, or diagnostic cut-offs.
Why it matters
This study highlights that monoallelic CYP21A2 mutations are not purely silent and can present with late-onset hyperandrogenic or PCOS-like features, proposing the 17OHP/cortisol ratio as a potential biochemical screening tool.
Limits
The abstract reports no numerical values, confidence intervals, or defined cut-offs for the 17OHP/cortisol ratio. The sample size is modest (33 carriers, 101 total subjects) and derived exclusively from a single regional cohort (Sicily), limiting broader generalizability.
Cited by
- supports Carrying two copies of a genetic mutation causing adrenal androgen overproduction (such as non-classical congenital adrenal hyperplasia) can cause infertility, whereas heterozygosity (carrying one copy) causes androgen overproduction without causing infertility.